HFE and hepatocellular carcinoma: Recently, an increased incidence of the HFE C282Y heterozygote mutation has been identified in HCC patients and correlated with excessive iron deposition in many organs, indicating a potential role of the HFE C282Y heterozygous state in hepatocarcinogenesis disease (Ye et al., 2016).